71 related articles for article (PubMed ID: 22410573)
1. The effect of low and ultra-low dosages Thymoglobulin on peripheral T, B and NK cells in kidney transplant recipients.
Kho MM; Bouvy AP; Cadogan M; Kraaijeveld R; Baan CC; Weimar W
Transpl Immunol; 2012 Jun; 26(4):186-90. PubMed ID: 22410573
[TBL] [Abstract][Full Text] [Related]
2. Low Total Dose of Anti-Human T-Lymphocyte Globulin (ATG) Guarantees a Good Glomerular Filtration Rate after Liver Transplant in Recipients with Pretransplant Renal Dysfunction.
Dopazo C; Charco R; Caralt M; Pando E; Lázaro JL; Gómez-Gavara C; Castells L; Bilbao I
Can J Gastroenterol Hepatol; 2018; 2018():1672621. PubMed ID: 30186817
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppression withdrawal in living-donor renal transplant recipients following induction with antithymocyte globulin and rituximab: Results of a prospective clinical trial.
Markmann JF; Burrell BE; Bromberg JS; Hartono C; Kaufman DB; Possselt AM; Naji A; Bridges ND; Breeden C; Kanaparthi S; Pardo J; Kopetskie H; Mason K; Lim N; Chandran S
Am J Transplant; 2024 Mar; ():. PubMed ID: 38467375
[TBL] [Abstract][Full Text] [Related]
4. Effect of Different Induction Immunosuppression on the Incidence of Infectious Complications after Kidney Transplantation-Single Center Study.
Vnučák M; Graňák K; Beliančinová M; Kleinová P; Blichová T; Doboš V; Dedinská I
J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673435
[No Abstract] [Full Text] [Related]
5. The role of Thymoglobulin induction in kidney transplantation: an update.
Mourad G; Morelon E; Noël C; Glotz D; Lebranchu Y
Clin Transplant; 2012; 26(5):E450-64. PubMed ID: 23061755
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of antibody induction therapy in the current era of kidney transplantation.
Opelz G; Unterrainer C; Süsal C; Döhler B
Nephrol Dial Transplant; 2016 Oct; 31(10):1730-8. PubMed ID: 27190386
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of induction treatment with low thymoglobulin doses in kidney transplantation from expanded-criteria donors.
Sancho Calabuig A; Gavela Martínez E; Kanter Berga J; Beltrán Calatán S; Avila Bernabeu AI; Pallardó Mateu LM
Transplant Proc; 2015; 47(1):50-3. PubMed ID: 25645768
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of thymoglobulin and basiliximab in kidney transplant patients at high risk for acute rejection and delayed graft function.
Chen G; Gu J; Qiu J; Wang C; Fei J; Deng S; Li J; Huang G; Fu Q; Chen L
Exp Clin Transplant; 2013 Aug; 11(4):310-4. PubMed ID: 23121641
[TBL] [Abstract][Full Text] [Related]
9. Single-dose antithymocyte globulin in standard immunological risk kidney transplant recipients: efficacy and kinetics of peripheral blood CD3
Machado FP; Rauber N; Vicari AR; Bauer AC; Manfro RC
J Nephrol; 2023 Nov; ():. PubMed ID: 37943422
[TBL] [Abstract][Full Text] [Related]
10. Evaluating anti-thymocyte globulin induction doses for better allograft and patient survival in Asian kidney transplant recipients.
Shim YE; Ko Y; Lee JP; Jeon JS; Jun H; Yang J; Kim MS; Lim SJ; Kwon HE; Jung JH; Kwon H; Kim YH; Lee J; Shin S;
Sci Rep; 2023 Aug; 13(1):12560. PubMed ID: 37532735
[TBL] [Abstract][Full Text] [Related]
11. Excellent efficacy and beneficial safety during observational 5-year follow-up of rapid steroid withdrawal after renal transplantation (Harmony FU study).
Stumpf J; Thomusch O; Opgenoorth M; Wiesener M; Pascher A; Woitas RP; Suwelack B; Rentsch M; Witzke O; Rath T; Banas B; Benck U; Sommerer C; Kurschat C; Lopau K; Weinmann-Menke J; Jaenigen B; Trips E; Hugo C
Nephrol Dial Transplant; 2023 Dec; 39(1):141-150. PubMed ID: 37391381
[TBL] [Abstract][Full Text] [Related]
12. A prospective, randomized, non-blinded, non-inferiority pilot study to assess the effect of low-dose anti-thymocyte globulin with low-dose tacrolimus and early steroid withdrawal on clinical outcomes in non-sensitized living-donor kidney recipients.
Ko Y; Wee YM; Shin S; Kim MJ; Choi MY; Kim DH; Lim SJ; Jung JH; Kwon H; Kim YH; Han DJ
PLoS One; 2023; 18(3):e0280924. PubMed ID: 36857393
[TBL] [Abstract][Full Text] [Related]
13. Very Low Dose Anti-Thymocyte Globulins Versus Basiliximab in Non-Immunized Kidney Transplant Recipients.
Masset C; Kerleau C; Blancho G; Hourmant M; Walencik A; Ville S; Kervella D; Cantarovich D; Houzet A; Giral M; Garandeau C; Dantal J;
Transpl Int; 2023; 36():10816. PubMed ID: 36819125
[TBL] [Abstract][Full Text] [Related]
14. The Role of Innate Immune Cells in the Prediction of Early Renal Allograft Injury Following Kidney Transplantation.
Jahn N; Sack U; Stehr S; Vöelker MT; Laudi S; Seehofer D; Atay S; Zgoura P; Viebahn R; Boldt A; Hau HM
J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294469
[TBL] [Abstract][Full Text] [Related]
15. Harnessing the B Cell Response in Kidney Transplantation - Current State and Future Directions.
Anwar IJ; DeLaura IF; Gao Q; Ladowski J; Jackson AM; Kwun J; Knechtle SJ
Front Immunol; 2022; 13():903068. PubMed ID: 35757745
[TBL] [Abstract][Full Text] [Related]
16. [Thymoglobulin as induction treatment in kidney transplantants with low immunological risk: a Moroccan experience].
Abouzid Z; Amar MA; Abdessater M; Alioubane M; Benjaafar A; Ouzeddoun N; Benamar L; Bayahia R; Bouattar T
Pan Afr Med J; 2022; 41():138. PubMed ID: 35519161
[TBL] [Abstract][Full Text] [Related]
17. Effects of Reduced-Dose Anti-Human T-Lymphocyte Globulin on Overall and Donor-Specific T-Cell Repertoire Reconstitution in Sensitized Kidney Transplant Recipients.
Aschauer C; Jelencsics K; Hu K; Gregorich M; Reindl-Schwaighofer R; Wenda S; Wekerle T; Heinzel A; Oberbauer R
Front Immunol; 2022; 13():843452. PubMed ID: 35281040
[TBL] [Abstract][Full Text] [Related]
18. Effect of Kidney Transplantation on Accelerated Immunosenescence and Vascular Changes Induced by Chronic Kidney Disease.
Ceprian N; Valera G; Caro J; Yuste C; Serroukh N; González de Pablos I; Oliva C; Figuer A; Praga M; Alique M; Ramirez R; Morales E; Carracedo J
Front Med (Lausanne); 2021; 8():705159. PubMed ID: 34646838
[TBL] [Abstract][Full Text] [Related]
19. CD5-Positive B Lymphocytes after Kidney Transplantation.
Zieliński M; Tarasewicz A; Zielińska H; Jankowska M; Sakowska J; Dukat-Mazurek A; Moszkowska G; Rutkowski B; Dębska-Ślizień A; Trzonkowski P
Diagnostics (Basel); 2021 Aug; 11(9):. PubMed ID: 34573916
[TBL] [Abstract][Full Text] [Related]
20. HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation.
Duygu B; Olieslagers TI; Groeneweg M; Voorter CEM; Wieten L
Front Immunol; 2021; 12():680480. PubMed ID: 34295330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
